Drug-induced non-palpable purpura in Infant/Neonate
Alerts and Notices
Important News & Links
Synopsis
Petechiae and non-palpable purpura (ecchymoses) secondary to medications occur as a result of hemorrhage into the skin. Except in those medications that lead to thrombocytopenia, petechial rashes are an unusual manifestation of drug eruption in pediatrics. Medications that cause thrombocytopenia or alter platelet function may manifest with petechiae and ecchymoses. Chemotherapeutic agents that cause generalized bone marrow suppression with thrombocytopenia are frequent culprits. Bleomycin has been reported to cause endothelial damage and leakage resulting in purpura. Anticoagulant therapy, serotonin reuptake inhibitors, and drug-induced vasculitis (leukocytoclastic vasculitis) may all present with dermal hemorrhage. Phenytoin, carbamazepine, and valproic acid may also cause purpura and vasculitis. Recently, the local anesthetic EMLA (eutectic mixture of lidocaine) has been described as causing petechiae and purpura at the sites of application with no alteration in hematologic indices.
Codes
ICD10CM:
D69.2 – Other nonthrombocytopenic purpura
T50.905A – Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
SNOMEDCT:
109957002 – Drug-induced purpura
D69.2 – Other nonthrombocytopenic purpura
T50.905A – Adverse effect of unspecified drugs, medicaments and biological substances, initial encounter
SNOMEDCT:
109957002 – Drug-induced purpura
Look For
Subscription Required
Diagnostic Pearls
Subscription Required
Differential Diagnosis & Pitfalls
To perform a comparison, select diagnoses from the classic differential
Subscription Required
Best Tests
Subscription Required
Management Pearls
Subscription Required
Therapy
Subscription Required
Drug Reaction Data
Subscription Required
References
Subscription Required
Last Updated:09/12/2017
Drug-induced non-palpable purpura in Infant/Neonate
